Abstract
BACKGROUND AND AIMS—Hereditary pancreatitis (HP) is a rare form of recurrent acute and chronic pancreatitis. Mutations in the cationic trypsinogen (protease serine 1, PRSS1) gene have been identified as causing HP. The R122H (previously known as R117H) mutation is the commonest and can be detected by a single and rapid polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP) based technique using the AflIII enzyme. This test however may give a false negative result in the presence of a neutral polymorphism within the enzyme recognition site. The frequency of this event was examined by sequencing studies in patients with HP and in healthy controls. METHODS—Of 60 families identified by the UK and Ireland consortium of EUROPAC (European Registry for Hereditary Pancreatitis and Familial Pancreatic Cancer), 51 were screened for R122H, N29I, and A16V mutations using standard techniques, and by sequencing of all five exons of cationic trypsinogen. RESULTS—Twelve families had the N29I mutation, one family had A16V and, on standard testing, 15 families had the R122H mutation. An additional family with the R122H mutation was found on direct sequencing. The false negative result was due to a neutral polymorphism C→T at the third base of the codon, not affecting the amino acid coded for, destroying the AflIII restriction site. This polymorphism was not observed in 50 DNA specimens (100 chromosomes) from controls nor from 50 individuals from PRSS1 mutation negative HP families. A novel mutation specific PCR was developed to avoid this pitfall. CONCLUSIONS—One of the 16 families with HP and an R122H mutation contained a polymorphism affecting the AflIII restriction site. Adoption of an alternative R122H assay is important for genetic studies in individuals with apparent HP. Keywords: hereditary pancreatitis; R122H mutation
Full Text
The Full Text of this article is available as a PDF (138.1 KB).
Figure 1 .
Family tree of pedigree III, illustrating multiple generations affected by hereditary pancreatitis and ductal adenocarcinoma of the pancreas.
Figure 2 .
Gel electrophoresis of DNA fragments against pBR322 Hae111 molecular weight markers, following nested polymerase chain reaction (PCR) amplification of exon 3 of PRSS1. Lane 1, individual IV-8; lane 2, individual III-16; lane 3, R122H positive control; lane 4, R122H negative control. Nested PCR amplification of DNA in lanes 1 and 2 produced two PCR products which indicates that those individuals are heterozygous for the R122H mutation.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cohn J. A., Friedman K. J., Noone P. G., Knowles M. R., Silverman L. M., Jowell P. S. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med. 1998 Sep 3;339(10):653–658. doi: 10.1056/NEJM199809033391002. [DOI] [PubMed] [Google Scholar]
- Creighton J. E., Lyall R., Wilson D. I., Curtis A., Charnley R. M. Mutations of the cationic trypsinogen gene in patients with hereditary pancreatitis. Br J Surg. 2000 Feb;87(2):170–175. doi: 10.1046/j.1365-2168.2000.01326.x. [DOI] [PubMed] [Google Scholar]
- Creighton J., Lyall R., Wilson D. I., Curtis A., Charnley R. Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis. Lancet. 1999 Jul 3;354(9172):42–43. doi: 10.1016/S0140-6736(99)01814-0. [DOI] [PubMed] [Google Scholar]
- Emi M., Nakamura Y., Ogawa M., Yamamoto T., Nishide T., Mori T., Matsubara K. Cloning, characterization and nucleotide sequences of two cDNAs encoding human pancreatic trypsinogens. Gene. 1986;41(2-3):305–310. doi: 10.1016/0378-1119(86)90111-3. [DOI] [PubMed] [Google Scholar]
- Finch M. D., Howes N., Ellis I., Mountford R., Sutton R., Raraty M., Neoptolemos J. P. Hereditary pancreatitis and familial pancreatic cancer. Digestion. 1997;58(6):564–569. doi: 10.1159/000201502. [DOI] [PubMed] [Google Scholar]
- Férec C., Raguénès O., Salomon R., Roche C., Bernard J. P., Guillot M., Quéré I., Faure C., Mercier B., Audrézet M. P. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet. 1999 Mar;36(3):228–232. [PMC free article] [PubMed] [Google Scholar]
- Férec C., Raguénès O., Salomon R., Roche C., Bernard J. P., Guillot M., Quéré I., Faure C., Mercier B., Audrézet M. P. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet. 1999 Mar;36(3):228–232. [PMC free article] [PubMed] [Google Scholar]
- Gorry M. C., Gabbaizedeh D., Furey W., Gates L. K., Jr, Preston R. A., Aston C. E., Zhang Y., Ulrich C., Ehrlich G. D., Whitcomb D. C. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology. 1997 Oct;113(4):1063–1068. doi: 10.1053/gast.1997.v113.pm9322498. [DOI] [PubMed] [Google Scholar]
- Konzen K. M., Perrault J., Moir C., Zinsmeister A. R. Long-term follow-up of young patients with chronic hereditary or idiopathic pancreatitis. Mayo Clin Proc. 1993 May;68(5):449–453. doi: 10.1016/s0025-6196(12)60193-1. [DOI] [PubMed] [Google Scholar]
- Layer P., Balzer K., Goebell H. Hereditary pancreatitis. Presentation of an additional family. Hepatogastroenterology. 1985 Feb;32(1):31–33. [PubMed] [Google Scholar]
- Le Bodic L., Bignon J. D., Raguénès O., Mercier B., Georgelin T., Schnee M., Soulard F., Gagne K., Bonneville F., Muller J. Y. The hereditary pancreatitis gene maps to long arm of chromosome 7. Hum Mol Genet. 1996 Apr;5(4):549–554. doi: 10.1093/hmg/5.4.549. [DOI] [PubMed] [Google Scholar]
- Lerch M. M., Ellis I., Whitcomb D. C., Keim V., Simon P., Howes N., Rutherford S., Domschke W., Imrie C., Neoptolemos J. P. Maternal inheritance pattern of hereditary pancreatitis in patients with pancreatic carcinoma. J Natl Cancer Inst. 1999 Apr 21;91(8):723–724. doi: 10.1093/jnci/91.8.723. [DOI] [PubMed] [Google Scholar]
- Lowenfels A. B., Maisonneuve P., Cavallini G., Ammann R. W., Lankisch P. G., Andersen J. R., Dimagno E. P., Andrén-Sandberg A., Domellöf L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med. 1993 May 20;328(20):1433–1437. doi: 10.1056/NEJM199305203282001. [DOI] [PubMed] [Google Scholar]
- Lowenfels A. B., Maisonneuve P., DiMagno E. P., Elitsur Y., Gates L. K., Jr, Perrault J., Whitcomb D. C. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst. 1997 Mar 19;89(6):442–446. doi: 10.1093/jnci/89.6.442. [DOI] [PubMed] [Google Scholar]
- Moir C. R., Konzen K. M., Perrault J. Surgical therapy and long-term follow-up of childhood hereditary pancreatitis. J Pediatr Surg. 1992 Mar;27(3):282–287. doi: 10.1016/0022-3468(92)90847-z. [DOI] [PubMed] [Google Scholar]
- Nishimori I., Kamakura M., Fujikawa-Adachi K., Morita M., Onishi S., Yokoyama K., Makino I., Ishida H., Yamamoto M., Watanabe S. Mutations in exons 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis. Gut. 1999 Feb;44(2):259–263. doi: 10.1136/gut.44.2.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paolini O., Hastier P., Buckley M., Maes B., Demarquay J. F., Staccini P., Bellon S., Caroli-Bosc F. X., Dumas R., Delmont J. The natural history of hereditary chronic pancreatitis: a study of 12 cases compared to chronic alcoholic pancreatitis. Pancreas. 1998 Oct;17(3):266–271. doi: 10.1097/00006676-199810000-00007. [DOI] [PubMed] [Google Scholar]
- Perrault J. Hereditary pancreatitis. Gastroenterol Clin North Am. 1994 Dec;23(4):743–752. [PubMed] [Google Scholar]
- Sahin-Tóth M. Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis. J Biol Chem. 2000 Jul 28;275(30):22750–22755. doi: 10.1074/jbc.M002943200. [DOI] [PubMed] [Google Scholar]
- Sharer N., Schwarz M., Malone G., Howarth A., Painter J., Super M., Braganza J. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 1998 Sep 3;339(10):645–652. doi: 10.1056/NEJM199809033391001. [DOI] [PubMed] [Google Scholar]
- Sossenheimer M. J., Aston C. E., Preston R. A., Gates L. K., Jr, Ulrich C. D., Martin S. P., Zhang Y., Gorry M. C., Ehrlich G. D., Whitcomb D. C. Clinical characteristics of hereditary pancreatitis in a large family, based on high-risk haplotype. The Midwest Multicenter Pancreatic Study Group (MMPSG) Am J Gastroenterol. 1997 Jul;92(7):1113–1116. [PubMed] [Google Scholar]
- Steer M. L., Waxman I., Freedman S. Chronic pancreatitis. N Engl J Med. 1995 Jun 1;332(22):1482–1490. doi: 10.1056/NEJM199506013322206. [DOI] [PubMed] [Google Scholar]
- Teich N., Mössner J., Keim V. Screening for mutations of the cationic trypsinogen gene: are they of relevance in chronic alcoholic pancreatitis? Gut. 1999 Mar;44(3):413–416. doi: 10.1136/gut.44.3.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vaughan D., Imrie C., Kelleher J., Drumm B., Osborne H. Pancreatic duct stenting as a treatment for hereditary pancreatitis. Pediatrics. 1999 Nov;104(5 Pt 1):1129–1133. doi: 10.1542/peds.104.5.1129. [DOI] [PubMed] [Google Scholar]
- Whitcomb D. C., Gorry M. C., Preston R. A., Furey W., Sossenheimer M. J., Ulrich C. D., Martin S. P., Gates L. K., Jr, Amann S. T., Toskes P. P. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996 Oct;14(2):141–145. doi: 10.1038/ng1096-141. [DOI] [PubMed] [Google Scholar]
- Whitcomb D. C. Hereditary pancreatitis: new insights into acute and chronic pancreatitis. Gut. 1999 Sep;45(3):317–322. doi: 10.1136/gut.45.3.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams R. A., Caldwell B. F., Wilson S. E. Idiopathic hereditary pancreatitis: experience with surgical treatment. Arch Surg. 1982 Apr;117(4):408–412. doi: 10.1001/archsurg.1982.01380280012003. [DOI] [PubMed] [Google Scholar]
- Witt H., Luck W., Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology. 1999 Jul;117(1):7–10. doi: 10.1016/s0016-5085(99)70543-3. [DOI] [PubMed] [Google Scholar]
- Witt H., Luck W., Hennies H. C., Classen M., Kage A., Lass U., Landt O., Becker M. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet. 2000 Jun;25(2):213–216. doi: 10.1038/76088. [DOI] [PubMed] [Google Scholar]


